102 related articles for article (PubMed ID: 8086986)
1. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi YA; Riekkinen P
BMJ; 1994 Sep; 309(6955):636-8. PubMed ID: 8086986
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease.
Lam LC; Tang NL; Ma SL; Lui VW; Chan AS; Leung PY; Chiu HF
Am J Alzheimers Dis Other Demen; 2006; 21(2):92-9. PubMed ID: 16634464
[TBL] [Abstract][Full Text] [Related]
3. Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.
Rapoport SI
Proc Natl Acad Sci U S A; 2000 May; 97(11):5696-8. PubMed ID: 10811924
[No Abstract] [Full Text] [Related]
4. Human Leukocyte Antigen as a Key Factor in Preventing Dementia and Associated Apolipoprotein E4 Risk.
James LM; Georgopoulos AP
Front Aging Neurosci; 2019; 11():82. PubMed ID: 31031617
[No Abstract] [Full Text] [Related]
5. Editorial: Neurotoxins in Alzheimer's disease and other dementias.
Henriques A; Poindron PLL; Fernando B; Hascup KN
Front Aging Neurosci; 2024; 16():1363466. PubMed ID: 38282691
[No Abstract] [Full Text] [Related]
6. Revealing third-order interactions through the integration of machine learning and entropy methods in genomic studies.
Yaldız B; Erdoğan O; Rafatov S; Iyigün C; Aydın Son Y
BioData Min; 2024 Jan; 17(1):3. PubMed ID: 38291454
[TBL] [Abstract][Full Text] [Related]
7. Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders.
Zhang X; Lucas AM; Veturi Y; Drivas TG; Bone WP; Verma A; Chung WK; Crosslin D; Denny JC; Hebbring S; Jarvik GP; Kullo I; Larson EB; Rasmussen-Torvik LJ; Schaid DJ; Smoller JW; Stanaway IB; Wei WQ; Weng C; Ritchie MD
Nat Commun; 2022 Jun; 13(1):3428. PubMed ID: 35701404
[TBL] [Abstract][Full Text] [Related]
8. Detection of presymptomatic Alzheimer's disease through breath biomarkers.
Emam S; Nasrollahpour M; Colarusso B; Cai X; Grant S; Kulkarni P; Ekenseair A; Gharagouzloo C; Ferris CF; Sun NX
Alzheimers Dement (Amst); 2020; 12(1):e12088. PubMed ID: 33088894
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk.
Corlier F; Hafzalla G; Faskowitz J; Kuller LH; Becker JT; Lopez OL; Thompson PM; Braskie MN
Neuroimage; 2018 May; 172():118-129. PubMed ID: 29357308
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.
Grimm MOW; Michaelson DM; Hartmann T
J Lipid Res; 2017 Nov; 58(11):2083-2101. PubMed ID: 28528321
[TBL] [Abstract][Full Text] [Related]
11. APP Function and Lipids: A Bidirectional Link.
Grimm MO; Mett J; Grimm HS; Hartmann T
Front Mol Neurosci; 2017; 10():63. PubMed ID: 28344547
[TBL] [Abstract][Full Text] [Related]
12. Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.
Reitz C
Expert Rev Mol Diagn; 2015 Mar; 15(3):339-48. PubMed ID: 25634383
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: A case-control study.
Cibeira GH; Giacomazzi J; Aguiar E; Schneider S; Ettrich B; DE Souza CI; Camey S; Caleffi M; Weber B; Ashton-Prolla P; Moriguchi EH
Mol Clin Oncol; 2014 Nov; 2(6):1009-1015. PubMed ID: 25279190
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.
Gharesouran J; Rezazadeh M; Khorrami A; Ghojazadeh M; Talebi M
J Mol Neurosci; 2014 Dec; 54(4):780-6. PubMed ID: 25022885
[TBL] [Abstract][Full Text] [Related]
15. At the interface of sensory and motor dysfunctions and Alzheimer's disease.
Albers MW; Gilmore GC; Kaye J; Murphy C; Wingfield A; Bennett DA; Boxer AL; Buchman AS; Cruickshanks KJ; Devanand DP; Duffy CJ; Gall CM; Gates GA; Granholm AC; Hensch T; Holtzer R; Hyman BT; Lin FR; McKee AC; Morris JC; Petersen RC; Silbert LC; Struble RG; Trojanowski JQ; Verghese J; Wilson DA; Xu S; Zhang LI
Alzheimers Dement; 2015 Jan; 11(1):70-98. PubMed ID: 25022540
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.
Reitz C; Mayeux R
Biochem Pharmacol; 2014 Apr; 88(4):640-51. PubMed ID: 24398425
[TBL] [Abstract][Full Text] [Related]
17. The APOE ɛ4 allele affects complexity and functional connectivity of resting brain activity in healthy adults.
Yang AC; Huang CC; Liu ME; Liou YJ; Hong CJ; Lo MT; Huang NE; Peng CK; Lin CP; Tsai SJ
Hum Brain Mapp; 2014 Jul; 35(7):3238-48. PubMed ID: 24193893
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association studies in Alzheimer's disease: a review.
Tosto G; Reitz C
Curr Neurol Neurosci Rep; 2013 Oct; 13(10):381. PubMed ID: 23954969
[TBL] [Abstract][Full Text] [Related]
19. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.
Bjerke M; Portelius E; Minthon L; Wallin A; Anckarsäter H; Anckarsäter R; Andreasen N; Zetterberg H; Andreasson U; Blennow K
Int J Alzheimers Dis; 2010 Jul; 2010():. PubMed ID: 20798852
[TBL] [Abstract][Full Text] [Related]
20. APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.
Keage HA; Matthews FE; Yip A; Gao L; McCracken C; McKeith IG; Rubinsztein DC; Brayne C;
Age Ageing; 2010 Jan; 39(1):104-11. PubMed ID: 19939808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
